ABOUT
TEAM
PORTFOLIO
NEWS
CONTACT
LP LOGIN
Select Page
Press Release
Media Contact
Maggie Jamison
mjamison@longitudecapital.com
650-854-5700
< Back to Longitude Capital News
Aptinyx Reports Results from Phase 2b Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy